CalciMedica CFO Stephen Bardin to resign after Q3 10-Q filing
The departure, disclosed in an October 16, 2026 filing, takes effect once the company submits its quarterly report for the period ended September 30, 2026.
CalciMedica, Inc. disclosed in an 8-K filing that Stephen Bardin, who serves as the company's chief financial officer and also holds the roles of principal accounting officer and principal financial officer, notified the company on October 15, 2026 that he plans to step down, with the resignation taking effect once CalciMedica files its Form 10-Q covering the quarter ended September 30, 2026.1 The company said Bardin is leaving to pursue another professional opportunity.1
The filing specified that Bardin's resignation was not due to any disagreement with the Company.1
The 8-K was filed under Item 5.02, covering departures and appointments of officers and directors. CalciMedica is incorporated in Delaware and trades on the Nasdaq Capital Market under the ticker CALC. The report was signed on October 16, 2026 by A. Rachel Leheny, Ph.D., the company's chief executive officer.
The filing does not name a successor CFO or provide further detail on timing beyond the planned effective date tied to the Q3 10-Q filing.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.